Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Etienne Bastien
Observed name:
E. Bastien
Institutions:
Centre Hospitalier Universitaire de Caen Normandie,
Institut Curie
Observed institutions:
Centre Hospitalier Universitaire de Caen Normandie,
Centre François Baclesse,
Institut Curie
ORCID:
0000-0002-9390-1523
Observed ORCID:
0000-0002-9390-1523
OpenAlex ID:
A5088208398
Post‐traumatic stress symptomatology and adjustment of medical oncology practice during the COVID‐19 pandemic among adult patients with cancer in a day care hospital
2021
·
Florence Joly
, Olivier Rigal
, et al.
·
Cancer
·
18
PDF
Transverse Myelitis Following SARS‐CoV ‐2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database
2022
·
Sophie Nguyen
, Etienne Bastien
, et al.
·
Annals of Neurology
·
15
Posttraumatic Stress Symptoms in Patients With Cancer During the COVID-19 Pandemic: A One-Year Longitudinal Study
2023
·
Etienne Bastien
, Sophie Lefèvre-Arbogast
, et al.
·
Journal of the National Comprehensive Cancer Network
·
13
PDF
Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization’s database
2023
·
Rachel Prevost
, Basile Chretien
, et al.
·
Frontiers in Pharmacology
·
9
PDF
LBA69 Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients
2020
·
F. Joly
, A. Leconte
, et al.
·
Annals of Oncology
·
7
PDF
Post-traumatic stress disorder symptoms and quality of life among older patients with cancer during the COVID-19 pandemic
2023
·
Francois Cherifi
, François Gernier
, et al.
·
Journal of Geriatric Oncology
·
6
PDF
Phase I trials of single-agent new drugs in head and neck cancer: a scoping review
2024
·
Daria Maria Filippini
, Gregoire Marret
, et al.
·
Chinese Clinical Oncology
·
4
334P Cardiovascular events related to CDK4/6 inhibitors: A systematic review and safety meta-analysis of randomized controlled trials
2024
·
L. Boismoreau
, C. Dolladille
, et al.
·
Annals of Oncology
·
1
PDF
Evolution of post-traumatic stress disorder and patient reported-outcomes during the COVID-19 pandemic among cancer patients of the French longitudinal COVIPACT study.
2021
·
Florence Joly
, Sophie Lefèvre-Arbogast
, et al.
·
Journal of Clinical Oncology
·
1
A systematic review of oral cancer drug therapies after metabolic bariatric surgery: what oncologists need to know about altered pharmacokinetics
2026
·
Aurélie Phan
, Etienne Bastien
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
A review on toxicities of T-cell engager-based therapies in solid tumors
2026
·
Etienne Bastien
, Clara Vacheret
, et al.
·
Therapeutic Advances in Medical Oncology
Ischaemic stroke and 5‐fluorouracil or capecitabine: A systematic review and meta‐analysis of harms and a retrospective study of the WHO pharmacovigilance database
2026
·
Sophie Nguyen
, Ines Bentahrour
, et al.
·
British Journal of Pharmacology
Clinical landscape for patients with head and neck cancers enrolled in phase I trials at a tertiary referral center
2025
·
Daria Maria Filippini
, Raphael Sanchez
, et al.
·
Therapeutic Advances in Medical Oncology
PDF
Does COVID ‐19 pandemic impact cancer outcomes in metastatic setting? A comparative cohort study among metastatic patients treated at day care hospital
2023
·
Florian Quilan
, Justine Lequesne
, et al.
·
Cancer Medicine
PDF
Show more works
View as search
Works count:
14
Citation count:
74
H-index:
6
I10-index:
3
Year
Topic
Type